124 related articles for article (PubMed ID: 30878390)
1. MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
Zhang L; Chen T; Yan L; Xu H; Wang Y; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Gene; 2019 Jun; 700():85-95. PubMed ID: 30878390
[TBL] [Abstract][Full Text] [Related]
2. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
3. Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer.
Lyu H; Wang S; Huang J; Wang B; He Z; Liu B
Cancer Lett; 2018 Apr; 420():97-108. PubMed ID: 29409974
[TBL] [Abstract][Full Text] [Related]
4. Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling.
Xu X; Lv YG; Yan CY; Yi J; Ling R
Biochem Biophys Res Commun; 2016 Oct; 479(4):893-900. PubMed ID: 27693788
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of MyD88 and association with paclitaxel resistance in breast cancer.
Xiang F; Ni Z; Zhan Y; Kong Q; Xu J; Jiang J; Wu R; Kang X
Tumour Biol; 2016 May; 37(5):6017-25. PubMed ID: 26596839
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression.
Chen Y; Huang S; Wu B; Fang J; Zhu M; Sun L; Zhang L; Zhang Y; Sun M; Guo L; Wang S
Oncotarget; 2017 Jul; 8(30):49110-49122. PubMed ID: 28418877
[TBL] [Abstract][Full Text] [Related]
10. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA SNHG15 promotes human breast cancer proliferation, migration and invasion by sponging miR-211-3p.
Kong Q; Qiu M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1594-1600. PubMed ID: 29217194
[TBL] [Abstract][Full Text] [Related]
12. miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.
Wang Y; Chen L; Wu Z; Wang M; Jin F; Wang N; Hu X; Liu Z; Zhang CY; Zen K; Chen J; Liang H; Zhang Y; Chen X
BMC Cancer; 2016 Nov; 16(1):826. PubMed ID: 27842510
[TBL] [Abstract][Full Text] [Related]
13. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
[TBL] [Abstract][Full Text] [Related]
14. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
Kong X; Zhang J; Li J; Shao J; Fang L
Biochem Biophys Res Commun; 2018 Jun; 501(2):486-493. PubMed ID: 29746865
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
Wang M; Zhang R; Zhang S; Xu R; Yang Q
Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion.
Sheng Y; Hu R; Zhang Y; Luo W
Clin Exp Med; 2020 Aug; 20(3):417-425. PubMed ID: 32279128
[TBL] [Abstract][Full Text] [Related]
17. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
18. MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1.
Ma F; Zhang L; Ma L; Zhang Y; Zhang J; Guo B
J Exp Clin Cancer Res; 2017 Nov; 36(1):158. PubMed ID: 29132384
[TBL] [Abstract][Full Text] [Related]
19. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.
Zhang Y; Wang Y; Wei Y; Li M; Yu S; Ye M; Zhang H; Chen S; Liu W; Zhang J
Sci Rep; 2015 Oct; 5():15424. PubMed ID: 26487539
[TBL] [Abstract][Full Text] [Related]
20. ATF-3/miR-590/GOLPH3 signaling pathway regulates proliferation of breast cancer.
Song Q; Chen Q; Wang Q; Yang L; Lv D; Jin G; Liu J; Li B; Fei X
BMC Cancer; 2018 Mar; 18(1):255. PubMed ID: 29534690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]